Cargando…

Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis

BACKGROUND: Diagnosis of human African trypanosomiasis (HAT) remains a challenge both for active screening, which is critical in control of the disease, and in the point-of-care scenario where early and accurate diagnosis is essential. Recently, the first field deployment of a lateral flow rapid dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Sternberg, Jeremy M., Gierliński, Marek, Biéler, Sylvain, Ferguson, Michael A. J., Ndung'u, Joseph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270746/
https://www.ncbi.nlm.nih.gov/pubmed/25521120
http://dx.doi.org/10.1371/journal.pntd.0003373
_version_ 1782349533372481536
author Sternberg, Jeremy M.
Gierliński, Marek
Biéler, Sylvain
Ferguson, Michael A. J.
Ndung'u, Joseph M.
author_facet Sternberg, Jeremy M.
Gierliński, Marek
Biéler, Sylvain
Ferguson, Michael A. J.
Ndung'u, Joseph M.
author_sort Sternberg, Jeremy M.
collection PubMed
description BACKGROUND: Diagnosis of human African trypanosomiasis (HAT) remains a challenge both for active screening, which is critical in control of the disease, and in the point-of-care scenario where early and accurate diagnosis is essential. Recently, the first field deployment of a lateral flow rapid diagnostic test (RDT) for HAT, “SD BIOLINE HAT” has taken place. In this study, we evaluated the performance of “SD BIOLINE HAT” and two new prototype RDTs. METHODOLOGY/PRINCIPAL FINDINGS: The performance of “SD BIOLINE HAT” and 2 prototype RDTs was tested using archived plasma from 250 Trypanosoma brucei gambiense patients, and 250 endemic controls. As well as comparison of the sensitivity and specificity of each device, the performance of individual antigens was assessed and the hypothetical performance of novel antigen combinations extrapolated. Neither of the prototype devices were inferior in sensitivity or specificity to “SD BIOLINE HAT” (sensitivity 0.82±0.01, specificity 0.97±0.01, 95% CI) at the 5% margins, while one of the devices (BBI) had significantly superior sensitivity (0.88±0.03). Analysis of the performance of individual antigens was used to model new antigen combinations to be explored in development of the next generation of HAT RDTs. The modelling showed that an RDT using two recombinant antigens (rLiTat1.5 and rISG65) would give a performance similar to the best devices in this study, and would also offer the most robust performance under deteriorating field conditions. CONCLUSIONS/SIGNIFICANCE: Both “SD BIOLINE HAT” and the prototype devices performed comparably well to one another and also to the published performance range of the card agglutination test for trypanosomiasis in sensitivity and specificity. The performance of individual antigens enabled us to predict that an all-recombinant antigen RDT can be developed with an accuracy equivalent to “ SD BIOLINE HAT.” Such an RDT would have advantages in simplified manufacture, lower unit cost and assured reproducibility.
format Online
Article
Text
id pubmed-4270746
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42707462014-12-26 Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis Sternberg, Jeremy M. Gierliński, Marek Biéler, Sylvain Ferguson, Michael A. J. Ndung'u, Joseph M. PLoS Negl Trop Dis Research Article BACKGROUND: Diagnosis of human African trypanosomiasis (HAT) remains a challenge both for active screening, which is critical in control of the disease, and in the point-of-care scenario where early and accurate diagnosis is essential. Recently, the first field deployment of a lateral flow rapid diagnostic test (RDT) for HAT, “SD BIOLINE HAT” has taken place. In this study, we evaluated the performance of “SD BIOLINE HAT” and two new prototype RDTs. METHODOLOGY/PRINCIPAL FINDINGS: The performance of “SD BIOLINE HAT” and 2 prototype RDTs was tested using archived plasma from 250 Trypanosoma brucei gambiense patients, and 250 endemic controls. As well as comparison of the sensitivity and specificity of each device, the performance of individual antigens was assessed and the hypothetical performance of novel antigen combinations extrapolated. Neither of the prototype devices were inferior in sensitivity or specificity to “SD BIOLINE HAT” (sensitivity 0.82±0.01, specificity 0.97±0.01, 95% CI) at the 5% margins, while one of the devices (BBI) had significantly superior sensitivity (0.88±0.03). Analysis of the performance of individual antigens was used to model new antigen combinations to be explored in development of the next generation of HAT RDTs. The modelling showed that an RDT using two recombinant antigens (rLiTat1.5 and rISG65) would give a performance similar to the best devices in this study, and would also offer the most robust performance under deteriorating field conditions. CONCLUSIONS/SIGNIFICANCE: Both “SD BIOLINE HAT” and the prototype devices performed comparably well to one another and also to the published performance range of the card agglutination test for trypanosomiasis in sensitivity and specificity. The performance of individual antigens enabled us to predict that an all-recombinant antigen RDT can be developed with an accuracy equivalent to “ SD BIOLINE HAT.” Such an RDT would have advantages in simplified manufacture, lower unit cost and assured reproducibility. Public Library of Science 2014-12-18 /pmc/articles/PMC4270746/ /pubmed/25521120 http://dx.doi.org/10.1371/journal.pntd.0003373 Text en © 2014 Sternberg et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sternberg, Jeremy M.
Gierliński, Marek
Biéler, Sylvain
Ferguson, Michael A. J.
Ndung'u, Joseph M.
Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis
title Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis
title_full Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis
title_fullStr Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis
title_full_unstemmed Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis
title_short Evaluation of the Diagnostic Accuracy of Prototype Rapid Tests for Human African Trypanosomiasis
title_sort evaluation of the diagnostic accuracy of prototype rapid tests for human african trypanosomiasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270746/
https://www.ncbi.nlm.nih.gov/pubmed/25521120
http://dx.doi.org/10.1371/journal.pntd.0003373
work_keys_str_mv AT sternbergjeremym evaluationofthediagnosticaccuracyofprototyperapidtestsforhumanafricantrypanosomiasis
AT gierlinskimarek evaluationofthediagnosticaccuracyofprototyperapidtestsforhumanafricantrypanosomiasis
AT bielersylvain evaluationofthediagnosticaccuracyofprototyperapidtestsforhumanafricantrypanosomiasis
AT fergusonmichaelaj evaluationofthediagnosticaccuracyofprototyperapidtestsforhumanafricantrypanosomiasis
AT ndungujosephm evaluationofthediagnosticaccuracyofprototyperapidtestsforhumanafricantrypanosomiasis